FAMCICLOVIR (Cipla USA Inc.)
Welcome to the PulseAid listing for the FAMCICLOVIR drug offered from Cipla USA Inc.. This DNA Polymerase Inhibitors [MoA],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cipla USA Inc. |
| NON-PROPRIETARY NAME: | Famciclovir |
| SUBSTANCE NAME: | FAMCICLOVIR |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | DNA Polymerase Inhibitors [MoA],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2011-03-21 |
| END MARKETING DATE: | 0000-00-00 |
FAMCICLOVIR HUMAN PRESCRIPTION DRUG Details:
| Item Description | FAMCICLOVIR from Cipla USA Inc. |
| LABELER NAME: | Cipla USA Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 125(mg/1) |
| START MARKETING DATE: | 2011-03-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69097-269_e31d2f5e-7321-470a-9fca-a59eb4b94f99 |
| PRODUCT NDC: | 69097-269 |
| APPLICATION NUMBER: | ANDA078278 |
Other FAMCICLOVIR Pharmaceutical Manufacturers / Labelers:
